instmctions): The critical role of inflammation in obesity and T2D is now well established. Under this Grant, we have focused on defining the roles of components of the NCoR/SMRT co-repressor complexes in inflammation, including TBL1/TBLR1 and GPS2, and the development of a new technology that has permitted us to examine interactions between distant genomic regions. We have identified a new mechanism by which GPS2 protects cells against a hyper-infiammatory state, and we have uncovered novel roles of ncRNAs in targeting co-regulatory complexes to discreet locations In the nucleus with speciflc transcriptional functions. In this Project, we will capitalize on these recent discoveries to advance three new Specific Aims.
In Specific Aim 1, we will delineate the molecular mechanisms by which GPS2, an NCoR/SMRT-associated protein, suppresses hyper-inflammatory transcriptional responses in both macrophages and adipose tissue. These studies will test the hypothesis that GPS2 functions to regulate PPARy activity and infiammatory responses by acting both in the nucleus as a component of NCoR co-repressor complexes, and at the plasma membrane as an inhibitor of cell surface receptors that mediate responses to inducers and amplifiers of inflammation.
In Specific Aim II, we will define the molecular and physiological roles of SMRT in macrophages and adipocytes. In concert with the unexpected findings by Projects 1 and 3 that deletion of the related co-repressor NCoR from either adipocytes or macrophages results in protection from obesity- induced insulin resistance, these studies may facilitate the identification of chemicals/ligands that selectively regulate insulin-sensitizing functions of nuclear receptors, such as PPARy.
In Specific Aim 1 11, we will test the hypothesis that pro-infiammatory gene activation requires regulated interactions of promoter-associated transcriptional co-regulators with non-coding RNAs resident in specific sub-nuclear architectural structures. We will investigate whether directed movements between these sub-nuclear structures are required for regulated gene expression. These studies will therefore explore conceptually new cellular mechanisms for transcriptional control of gene expression that may be targets for therapeutic intervention.
The proposed studies will be of significance in advancing our understanding of central pathogenic mechanisms that drive the development of insulin resistance and contribue to the development of future therapeutic approaches to prevent and treat type 2 diabetes.
|Franck, Niclas; Maris, Michael; Nalbandian, Sarah et al. (2014) Knock-down of IL-1Ra in obese mice decreases liver inflammation and improves insulin sensitivity. PLoS One 9:e107487|
|Lee, Yun Sok; Kim, Jung-whan; Osborne, Olivia et al. (2014) Increased adipocyte O2 consumption triggers HIF-1?, causing inflammation and insulin resistance in obesity. Cell 157:1339-52|
|Oh, Da Young; Walenta, Evelyn; Akiyama, Taro E et al. (2014) A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat Med 20:942-7|
|Bhargava, Vipul; Head, Steven R; Ordoukhanian, Phillip et al. (2014) Technical variations in low-input RNA-seq methodologies. Sci Rep 4:3678|
|Suh, Jae Myoung; Jonker, Johan W; Ahmadian, Maryam et al. (2014) Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature 513:436-9|
|McNelis, Joanne C; Olefsky, Jerrold M (2014) Macrophages, immunity, and metabolic disease. Immunity 41:36-48|
|Johnson, Andrew M F; Olefsky, Jerrold M (2013) The origins and drivers of insulin resistance. Cell 152:673-84|
|Dinasarapu, Ashok Reddy; Gupta, Shakti; Ram Maurya, Mano et al. (2013) A combined omics study on activated macrophages--enhanced role of STATs in apoptosis, immunity and lipid metabolism. Bioinformatics 29:2735-43|
|Bhargava, Vipul; Ko, Pang; Willems, Erik et al. (2013) Quantitative transcriptomics using designed primer-based amplification. Sci Rep 3:1740|
|Spann, Nathanael J; Glass, Christopher K (2013) Sterols and oxysterols in immune cell function. Nat Immunol 14:893-900|
Showing the most recent 10 out of 69 publications